Company logo

INCY - Incyte Corporation

NASDAQ -> Healthcare -> Biotechnology
Wilmington, United States
Type: Equity

INCY price evolution
INCY
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $3215.22 $3228.95 $3132.84 $2822.77
Short term investments $442.67 $289.22 $292.24 $291.66
Net receivables $743.56 $657.26 $637.99 $623.79
Inventory $269.94 $199.29 $177.99 $157.56
Total current assets $4645.4 $4402.66 $4264.43 $3971.63
Long term investments $187.72 $153.66 $170.32 $128.31
Property, plant & equipment $777.05 $757.93 $774.98 $767.55
Goodwill & intangible assets $279.14 $284.84 $290.55 $296.25
Total noncurrent assets $2136.7 $1985.57 $1943.83 $1825.99
Total investments $630.38 $442.89 $462.56 $419.97
Total assets $6782.11 $6388.24 $6208.26 $5797.62
Current liabilities
Accounts payable $109.6 $139.41 $155.54 $55.63
Deferred revenue
Short long term debt $3.44 $3.06 $3.17 $3.15
Total current liabilities $1240.38 $1124.68 $1118.77 $1006.11
Long term debt $29.16 $28.86 $29.49 $29.7
Total noncurrent liabilities $351.89 $332.11 $348.79 $328.94
Total debt $32.6 $31.92 $32.66 $32.85
Total liabilities $1592.27 $1456.79 $1467.57 $1335.06
Shareholders' equity
Retained earnings $160.38 -$40.69 -$211.96 -$415.51
Other shareholder equity $13.11 $22.89 $26.81 $20.94
Total shareholder equity $5189.84 $4931.45 $4740.69 $4462.57
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $3215.22 $2953.12 $2059.16 $1514.77
Short term investments $442.67 $287.54 $290.75 $288.37
Net receivables $743.56 $644.88 $616.3 $481.99
Inventory $269.94 $41.99 $56.94 $35.97
Total current assets $4645.4 $4092.85 $3118.67 $2359.89
Long term investments $187.72 $133.68 $221.27 $222.3
Property, plant & equipment $777.05 $765.61 $751.47 $588.08
Goodwill & intangible assets $279.14 $284.81 $306.35 $327.88
Total noncurrent assets $2136.7 $1748.13 $1814.68 $1201.02
Total investments $630.38 $421.22 $512.02 $510.67
Total assets $6782.11 $5840.98 $4933.35 $3560.92
Current liabilities
Accounts payable $109.6 $277.55 $172.11 $98.77
Deferred revenue
Short long term debt $3.44 $3.18 $2.63 $2.28
Total current liabilities $1240.38 $1157.08 $854.31 $631.2
Long term debt $29.16 $30.08 $31.63 $32.57
Total noncurrent liabilities $351.89 $313.79 $309.04 $318.45
Total debt $32.6 $33.26 $34.27 $34.86
Total liabilities $1592.27 $1470.87 $1163.35 $949.65
Shareholders' equity
Retained earnings $160.38 -$437.21 -$777.87 -$1726.45
Other shareholder equity $13.11 $15.07 -$19.45 -$15.36
Total shareholder equity $5189.84 $4370.12 $3770 $2611.27
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $1013.34 $919.02 $954.61 $808.67
Cost of revenue $69.75 $60.09 $68.33 $56.82
Gross Profit $943.59 $858.93 $886.28 $751.85
Operating activities
Research & development $444.49 $375.71 $400.75 $406.64
Selling, general & administrative $293.87 $267.89 $283.93 $315.61
Total operating expenses $756.32 $644.23 $692.5 $727.08
Operating income $187.27 $214.71 $193.78 $24.77
Income from continuing operations
EBIT $271.76 $234.42 $278.26 $52.33
Income tax expense $69.88 $62.53 $74.06 $30.15
Interest expense $0.8 $0.62 $0.66 $0.47
Net income
Net income $201.08 $171.27 $203.55 $21.7
Income (for common shares) $201.08 $171.27 $203.55 $21.7
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $3695.65 $3394.64 $2986.27 $2666.7
Cost of revenue $254.99 $207 $150.99 $131.33
Gross Profit $3440.66 $3187.64 $2835.28 $2535.37
Operating activities
Research & development $1627.59 $1585.94 $1458.18 $2215.94
Selling, general & administrative $1161.29 $1002.14 $739.56 $516.92
Total operating expenses $2820.13 $2608.2 $2234.76 $2775.66
Operating income $620.52 $579.44 $600.52 -$240.29
Income from continuing operations
EBIT $836.77 $531.78 $572.35 -$230.04
Income tax expense $236.62 $188.46 -$378.14 $63.48
Interest expense $2.55 $2.67 $1.91 $2.17
Net income
Net income $597.6 $340.66 $948.58 -$295.7
Income (for common shares) $597.6 $340.66 $948.58 -$295.7
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $201.08 $171.27 $203.55 $21.7
Operating activities
Depreciation $21.76 $21.39 $20.3 $19.21
Business acquisitions & disposals
Stock-based compensation $59.99 $48 $54.52 $53.38
Total cash flows from operations $147.73 $147.84 $306.53 -$105.6
Investing activities
Capital expenditures -$2.27 -$10.98 -$7.34 -$26.91
Investments -$152.23 -$6.21 -$0.09 -$1.65
Total cash flows from investing -$154.5 -$17.19 -$7.43 -$28.56
Financing activities
Dividends paid
Sale and purchase of stock $7.52 -$0.05 $14.38 $13.99
Net borrowings -$0.84 -$0.89 -$0.84 -$0.8
Total cash flows from financing $0.35 -$37.26 $12.87 $4.01
Effect of exchange rate -$7.3 $2.71 -$1.89 -$0.2
Change in cash and equivalents -$13.73 $96.11 $310.07 -$130.35
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $597.6 $340.66 $948.58 -$295.7
Operating activities
Depreciation $82.66 $67.86 $57.84 $51.81
Business acquisitions & disposals
Stock-based compensation $215.89 $188.42 $183.01 $177.88
Total cash flows from operations $496.49 $969.94 $749.49 -$124.6
Investing activities
Capital expenditures -$32.49 -$77.83 -$181.01 -$187.38
Investments -$160.19 -$0.71 -$26.69 -$81.62
Total cash flows from investing -$207.68 -$78.54 -$207.7 -$269
Financing activities
Dividends paid
Sale and purchase of stock $35.84 $61.12 $58.63 $110.31
Net borrowings -$3.36 -$2.86 -$2.42 -$0.84
Total cash flows from financing -$20.03 -$0.79 $6.18 $71.71
Effect of exchange rate -$6.68 $3.35 -$3.57 $2.95
Change in cash and equivalents $262.1 $893.96 $544.39 -$318.94
Fundamentals
Market cap $12.78B
Enterprise value $9.60B
Shares outstanding 224.29M
Revenue $3.70B
EBITDA $919.43M
EBIT $836.77M
Net Income $597.60M
Revenue Q/Q 9.35%
Revenue Y/Y 8.87%
P/E ratio 21.38
EV/Sales 2.60
EV/EBITDA 10.44
EV/EBIT 11.47
P/S ratio 3.46
P/B ratio 2.47
Book/Share 23.08
Cash/Share 14.34
EPS $2.66
ROA 9.49%
ROE 12.37%
Debt/Equity 0.31
Net debt/EBITDA -1.77
Current ratio 3.75
Quick ratio 3.53